The startup has developed a patented drug delivery device platform that enables reliable intradermal injections for therapeutic, prophylactic, and allergy treatments. This technology provides healthcare providers with a standardized and accurate method for administering vaccines and medications in the dermal layer of the skin, enhancing ease of use and consistency in patient care.
Funding
$930K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional intradermal injections often lack standardization, require specialized training, and can result in inconsistent drug delivery due to the manual technique required. This can lead to variable immune responses in prophylactic vaccination and reduced efficacy in therapeutic drug delivery.
Solution
Idevax offers the VAX-ID® platform, a patented drug delivery device designed to standardize and simplify intradermal injections for both prophylactic and therapeutic applications. The device ensures accurate and reliable delivery of vaccines and medications into the dermal layer of the skin, optimizing immune response and therapeutic outcomes. VAX-ID® addresses the limitations of manual intradermal injection techniques by providing a user-friendly device that minimizes variability and enhances safety through features like needle-stick injury prevention. The device is available for research use and is CE marked as a Class IIa medical device for distribution within the European Economic Area.
Target Audience
The primary target audience includes healthcare providers administering vaccines, researchers conducting intradermal drug delivery studies, and pharmaceutical companies developing novel intradermal therapies.
Features
- Predefined penetration depth with options for 32G, 30G, or 27G needles, allowing for average injection depths of 0.5 mm, 0.6 mm, and 0.8 mm, respectively
- Activation protection mechanism to prevent accidental needle deployment
- Integrated needle-stick injury prevention
- Ergonomic design for ease of use by healthcare professionals
- Compatibility with standard syringes
- Validated for delivery of cell-based therapies without causing cell damage from shear stress
- Available in both sterile and to-be-sterilized configurations